Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Public ClinicalTrials.gov record NCT01425359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Randomized, Double-Blind, Placebo-Controlled, Parallel Study of Ranolazine in Subjects With Chronic Stable Angina and Coronary Artery Disease With a History of Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the effect of ranolazine compared to placebo on the average weekly angina frequency in subjects with chronic stable angina and coronary artery disease (CAD) who have a history of type 2 diabetes mellitus (T2DM), and whether ranolazine can reduce the frequency of angina (chest pain) attacks, compared to a placebo. Subjects will be asked to record their daily angina episodes in a diary at the end of each study day. Ranolazine is approved for the treatment of chronic angina, and is not approved for the treatment of T2DM.
Study identification
- NCT ID
- NCT01425359
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 949 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2011 (Type not available)
- Primary completion
- Oct 2012 (Actual)
- Completion
- Oct 2012 (Actual)
- Last update posted
- Nov 4, 2014
2011 – 2012
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiology and Medicine Clinic | Little Rock | Arkansas | 72204 | — |
| Merced Heart Associates | Merced | California | 95340 | — |
| Spectrum Clinical Research Institute, Inc | Moreno Valley | California | 92553 | — |
| Sacramento Heart and Vascular Research Center | Sacramento | California | 95825 | — |
| South Florida Research Solutions, LLC | Hollywood | Florida | 33021 | — |
| Baptist Heart Specialist | Jacksonville | Florida | 32207 | — |
| Clinical Research of Central Florida | Winter Haven | Florida | 33880 | — |
| Masters of Clinical Research, Inc. | Augusta | Georgia | 30909 | — |
| Columbus Cardiology Associates | Columbus | Georgia | 31909 | — |
| Central Cardiology Associates | Elizabethtown | Kentucky | 42701 | — |
| Research Integrity, LLC | Owensboro | Kentucky | 42303 | — |
| Alexandria Cardiology Clinic | Alexandria | Louisiana | 71301 | — |
| Clinical Trials Management, LLC | Mandeville | Louisiana | 70471 | — |
| Endeavor Medical Research, PLC | Alpena | Michigan | 49707 | — |
| Minneapolis Heart Institute Foundation | Minneapolis | Minnesota | 55407 | — |
| Cross Country Cardiology | Edgewater | New Jersey | 07020 | — |
| Kore CV Research | Jackson | Tennessee | 38305 | — |
| Wellmont Cardiovascular Associates Heart Institute | Johnson City | Tennessee | 37604 | — |
| Med-Tech Research | Houston | Texas | 77024 | — |
| Humble Cardiology Associates | Humble | Texas | 77338 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01425359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 4, 2014 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01425359 live on ClinicalTrials.gov.